Tuesday 28 June 2016

Global generic drugs market to grow at a CAGR of 10.53% during the period 2016-2020

About the Generic Drugs Market

Generic drugs have the same chemical formula, dosage form, potency, route of administration, quality, and intended use as that of patented branded drugs. They cost 80%-85% lesser than their branded counterparts and are available soon after the patent expiries of original drugs. However, they are similar to original drugs in terms of safety, quality, and effectiveness. Manufacturers need to apply for an Abbreviated New Drug Application (ANDA) approval to receive approval of generics.


Covered in this report 
The report covers the present scenario and the growth prospects of the global generic drugs market for 2016-2020. To calculate the market size, it considers revenue generated from the sales of simple generics, super generics, and biosimilars.

The market is divided into the following segments based on geography: 
Americas
APAC
EMEA

Technavio's report, Global Generic Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors 
Teva Pharmaceuticals
Sandoz
Allergan
Mylan
Sun Pharmaceuticals
STADA Arzneimittel

Other prominent vendors 
Abbott
Amgen 
Apotex
Aspen
Biocon

Read All Medical Equipments Market Research Reports @ http://www.researchmoz.us/medical-equipments-market-reports-109.html

Biogen
Boehringer Ingelheim 
Celltrion 
Cipla
Coherus Biosciences
Dr. Reddy's Laboratory
Daiichi Sankyo
Eli Lilly 
Emcure Pharmaceuticals 
Eurofarma Laboratories 
Gedeon Richter
Gilead Sciences
GlaxoSmithKline 
Hospira 
Impax 
InnoPharma 
Intas Pharmaceuticals 
Jannsen
Lupin

Market driver 
Patent expiry of top-selling drugs
For a full, detailed list, view our report

Market challenge 
Threat of counterfeit drugs 
For a full, detailed list, view our report

Market trend 
Outsourcing of drug development activities
For a full, detailed list, view our report

Key questions answered in this report 
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?

Download Free exclusive Sample of this report: http://www.researchmoz.us/enquiry.php?type=S&repid=729247

What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.

For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare, +1–518–621–2074
USA-Canada Toll Free: 866–997–4948
Follow us on LinkedIn at: http://bit.ly/1TBmnVG

Global smoking cessation products market to grow at a CAGR of 18.16% during the period 2016-2020

About Smoking Cessation Products

Smoking cessation products such as NRTs and e-cigarettes have proved useful in reducing the numbers of smokers worldwide. They can also be used to reduce smoking. A substantial number of smokers are now either quitting or trying to reduce smoking. This is because of increased awareness about the adverse effects of smoking; it is associated with a number of health hazards that can eventually lead to death. This is encouraging people to adopt smoking cessation products. Public awareness programs help create awareness about the hazards of smoking, and also the availability of products that help quit smoking.


Covered in this report 
The report covers the present scenario and the growth prospects of the global smoking cessation products market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of prescription, generic, off-label, and over-the-counter (OTC) products used for smoking cessation.

The market is divided into the following segments based on geography: 
Americas
APAC
EMEA

Technavio's report, Global Thoracic Surgery Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors 
GlaxoSmithKline
Imperial Tobacco
NJOY
Pfizer 
Reynolds American

Other prominent vendors 
22nd Century Group
Alkalon
Altria Group
Aradigm
Arena Pharmaceuticals
Ballantyne Brands
British American Tobacco (BAT)
CB Distributors
Cytos Biotechnology
Electronics Cigarettes International Group (Victory Electronic Cigarettes)
Evotec
Gamucci
Japan Tobacco
Johnson & Johnson
LOGIC Technology
NAL Pharmaceuticals

Read All Medical Equipments Market Research Reports @ http://www.researchmoz.us/medical-equipments-market-reports-109.html

Nicotek
Novartis
Revolymer
RR Chemicals
Selecta Biosciences
Target
The Harvard Drug Group
Vapor
VMR Products
Walgreens
Wal-Mart
White Cloud

Market driver 
High awareness of risks associated with tobacco use
For a full, detailed list, view our report

Market challenge 
Relapse after treatment
For a full, detailed list, view our report

Market trend 
Ban on tobacco advertisements
For a full, detailed list, view our report

Key questions answered in this report 
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?

Download Free exclusive Sample of this report: http://www.researchmoz.us/enquiry.php?type=S&repid=715923

What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.

For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare, +1–518–621–2074
USA-Canada Toll Free: 866–997–4948
Follow us on LinkedIn at: http://bit.ly/1TBmnVG

Global alpha-1 antitrypsin drugs market to grow at a CAGR of 35.42% during the period 2016-2020

About Alpha-1 antitrypsin Drugs

Alpha-1 antitrypsin, also known as an alpha-1 protease inhibitor (A1PI), is a glycoprotein produced in the liver that helps in the inactivation of enzymes such as elastase, which break down proteins during inflammation induced by some injury. The decline in alpha-1 antitrypsin levels in the blood results in a rare genetic condition known as alpha-1 antitrypsin deficiency (AATD), which leads to the development of respiratory and liver diseases, and severe skin infections. The disease is passed on from parents to an offspring through mutated genes. Augmentation therapy using drugs derived from human plasma helps in maintaining levels of alpha-1 antitrypsin in the blood, helping in remission of the condition.


Covered in this report 
The report covers the present scenario and the growth prospects of the global alpha-1 antitrypsin drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded drugs and off-label drugs used for the symptomatic treatment of diseases occurring due to alpha-1 antitrypsin deficiency and other disorders.

The market is divided into the following segments based on geography: 
Americas
APAC
EMEA

Technavio's report, Global Alpha-1 Antitrypsin Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors 
Baxter International
CSL Behring
Grifols
Kamada

Other prominent vendors 
Abeona Therapeutics
Alnylam Pharmaceuticals
Applied Genetic Technologies
Arrowhead Research
Baxalta
Biogen
Chiesi


Curaxys
Laboratoire franais du Fractionnement et des Biotechnologies
ProBioGen
ProMetic Life Sciences

Market driver 
Improved diagnosis of alpha-1 antitrypsin deficiency (AATD)
For a full, detailed list, view our report

Market challenge 
Limited plasma fractionation capacity
For a full, detailed list, view our report

Market trend 
Increasing awareness about therapy 
For a full, detailed list, view our report

Key questions answered in this report 
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?

Read All Medical Equipments Market Research Reports @ http://www.researchmoz.us/medical-equipments-market-reports-109.html

What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.

For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare, +1–518–621–2074
USA-Canada Toll Free: 866–997–4948
Follow us on LinkedIn at: http://bit.ly/1TBmnVG

Global thoracic surgery market to grow at a CAGR of 10.16% during the period 2016-2020

About Thoracic Surgery

Thoracic surgery involves surgical treatment (open surgery or minimally invasive surgery) to address medical conditions involving the heart or lungs. It includes procedures such as redo heart surgery, aortic dissection for aortic surgery, minimally invasive mitral valve repair and replacement, and endovascular repair of thoracic aortic aneurysms. It is performed to treat end-stage heart failure, heart-lung transplants, and placement of ventricular-assist devices.


Covered in this report 
The report covers the present scenario and the growth prospects of the global thoracic surgery market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of medical devices required for thoracic surgeries

The market is divided into the following segments based on geography: 
Americas
APAC
EMEA

Technavio's report, Global Thoracic Surgery Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors 
Boston Scientific
Medtronic
Sorin
St. Jude Medical
Terumo

Other prominent vendors 
Abbott Vascular
Abiomed
AtriCure
Biosensors International
Biotronik
BioVentrix
C. R. Bard
Cardiac Assist

Read All Medical Equipments Market Research Reports @ http://www.researchmoz.us/medical-equipments-market-reports-109.html

CircuLite
Cordis
Corindus Vascular Robotics
CryoLife
CVRX
Edwards Lifesciences
HeartWare
Intuitive Surgical
Jarvik Heart
MAQUET Cardiovascular
Merit Medical Systems
MicroMed Cardiovascular
On-X Life Technologies
OrbusNeich
Qvanteq
Spectranetics
Sunshine Heart
SynCardia Systems
Thoratec
Volcano

Market driver 
Rise in incidence of cardiac disorders and increase in aging population
For a full, detailed list, view our report

Market challenge 
Potential complications associated with cardiac surgery
For a full, detailed list, view our report

Market trend 
Growing popularity of robot-assisted cardiac surgery
For a full, detailed list, view our report

Download Free exclusive Sample of this report: http://www.researchmoz.us/enquiry.php?type=S&repid=715901

Key questions answered in this report 
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.

For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare, +1–518–621–2074
USA-Canada Toll Free: 866–997–4948
Follow us on LinkedIn at: http://bit.ly/1TBmnVG

Global endocrinology drugs market to grow at a CAGR of 6.69% during the period 2016-2020

About Endocrinology Drugs

Endocrinology deals with the study of the endocrine system, including the biochemical and physiological functions of the hormones, cells, and tissues of the endocrine glands. Endocrine disorders can be broadly subdivided into three categories: endocrine gland hyposecretion, which causes hormone deficiency, endocrine gland hypersecretion, which causes excess hormone secretion, and tumors in the endocrine gland. The endocrine disorders considered for the present report include diabetes, human growth hormone deficiency, thyroid disorders, and male hypogonadism.



Covered in this report 
The report covers the present scenario and the growth prospects of the global endocrinology drugs market for 2015-2020. To calculate the market size, the report considers revenue generated from the sales of branded drugs, generics, and biosimilars used to treat and prevent type 1 and type 2 diabetes, human growth hormone deficiency, hypogonadism, and thyroid gland disorders.

The market is divided into the following segments based on geography: 
Americas
APAC
EMEA

Technavio's report, Global Endocrinology Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors 
AbbVie Inc.
AstraZeneca PLC
Eli Lilly and Co.
Merck & Co
Novo Nordisk AS
Sanofi SA

Other prominent vendors 
Acerus Pharmaceuticals 
Acrux DDS
Adocia
terna Zentaris
Akros Pharma
Allergan
Amgen
Antares Pharma
Ascendis Pharma
Astellas Pharma
Baxalta
Bayer HealthCare Pharmaceuticals
BHV Pharma
Biocon
Biodel
Boehringer Ingelheim
ChipScreen Biosciences
Clarus Therapeutics
ConjuChem
Critical Pharmaceuticals
CureDm
CymaBay Therapeutics
Daiichi Sankyo
Dance Biopharm
DiaMedica
Diamyd Therapeutics
Diasome Pharmaceuticals
DiaVacs
Dong-A ST
Eisai
Elcelyx Therapeutics
Endo Pharmaceuticals
Exsulin
Ferring Pharmaceuticals
Gan & Lee Pharmaceuticals

Read All Medical Equipments Market Research Reports @ http://www.researchmoz.us/medical-equipments-market-reports-109.html


Genentech
Generex
Genexine
Genfit
GSK
HanAll BioPharma
Hanmi Pharmaceutical 
Hua Medicine
ILTOO Pharma
Intarcia Therapeutics
InteKrin Therapeutics
Intrexon
Ionis Pharmaceuticals
Ipe
Islet Sciences
Janssen Pharmaceuticals
Japan Tobacco
Juniper Pharmaceuticals
Kadmon Corporation
Kamada 
KinDex Pharmaceuticals
Kissei Pharmaceutical
Kotobuki
Lexicon Pharmaceuticals
LG Life Sciences
Ligand Pharmaceuticals
Lipocine
Living Cell Technologies
MacroGenics
MannKind
MedImmune
Melior Pharmaceuticals
Metabolic Solutions Development Company
MetP Pharma
Mitsubishi Tanabe Pharma
Mylan
NGM Biopharmaceuticals
Novartis
NuSirt Biopharma
OPKO Biologics
Oramed Pharmaceuticals
Osiris Therapeutics
Peptron
Perle Biosciences
Pfizer
PhaseBio Pharmaceuticals
Poxel
ProStrakan Group
REGiMMUNE
Repros Therapeutics
Roche
Sanwa Kagaku Kenkyusho
Sirona Biochem
Strongbridge Biopharma
Takeda Pharmaceuticals
TesoRx Pharma
Teva Pharmaceutical
Theracos
Theratechnologies
Toleranzia
Tolerion
Transition Therapeutics
VeroScience 
Versartis
vTv Therapeutics
XBiotech
Xeris Pharmaceuticals
XOMA

Market driver 
Increase in prevalence of endocrine hormone-related diseases
For a full, detailed list, view our report

Market challenge 
Generic erosion
For a full, detailed list, view our report

Download Free exclusive Sample of this report: http://www.researchmoz.us/enquiry.php?type=S&repid=711552

Market trend 
Increase in outsourcing 
For a full, detailed list, view our report

Key questions answered in this report 
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.

For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare, +1–518–621–2074
USA-Canada Toll Free: 866–997–4948
Follow us on LinkedIn at: http://bit.ly/1TBmnVG

Global immunoglobulin products market to grow at a CAGR of 6.84% during the period 2016-2020

About Immunoglobulin Products

Immunoglobulins, also known as antibodies, are proteins that help neutralize foreign objects such as bacteria and viruses. They help recognize and bind to particular antigens. Based on the difference in the amino acid sequence in the fragment crystallizable (Fc) region of the antibody heavy chain, they can be categorized into the following isotypes: IgA, IgD, IgE, IgG, and IgM. In 1952, immunoglobulin products were used for the first time to treat immune deficiency. They can be administered by either the intravenous (IV) or subcutaneous (SC) route. Immunoglobulin products given intravenously usually contain IgG. Immunoglobulin products are used to treat primary antibody deficiency, complex immune deficiency disorders, and life threatening infections. Immunoglobulin therapeutic products help prevent infections, improving the quality of life and increasing life expectancy.



Covered in this report 
The report covers the present scenario and the growth prospects of the global immunoglobulin products market for the period 2015-2020. To calculate the market size, the report considers revenue generated from the sales of immunoglobulin products used to treat various autoimmune and immunodeficiency diseases.

The market is divided into the following segments based on geography: 
Americas
APAC
EMEA

Technavio's report, Global Immunoglobulin Products Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors 
Baxalta
Biotest Pharmaceuticals Corp.
CSL Ltd.
Grifols SA
Kedrion SpA
Octapharma

Other prominent vendors 
Abeona Therapeutics
Admabiologics
Anthera
Beijing Tiantan Biological Products (China)
Bharat Serums and Vaccines (India)
Bio Products Laboratory
China Biologic Products (China)
Emergent Biosolutions
Gliknik
Greencross
Hansamedical

Read All Medical Equipments Market Research Reports @ http://www.researchmoz.us/medical-equipments-market-reports-109.html

Hualan Biological Engineering (China)
Immunomedics
Innate Pharma
Integrated Biotherapeutics
Janssen Pharmaceuticals
Kamada
LFB Group (France)
Mitsubishi Tanabe Pharma
Momenta Pharma
Patrys
Shanghai RAAS Blood Products (China)
Sichuan Yuanda Shuyang Pharmaceutical (China)
Sorrento Therapeutics

Market driver 
Growing aging population
For a full, detailed list, view our report

Market challenge 
High cost of therapy
For a full, detailed list, view our report

Market trend 
Patient assistance programs 
For a full, detailed list, view our report

Download Free exclusive Sample of this report: http://www.researchmoz.us/enquiry.php?type=S&repid=711501

Key questions answered in this report 
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.

For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare, +1–518–621–2074
USA-Canada Toll Free: 866–997–4948
Follow us on LinkedIn at: http://bit.ly/1TBmnVG

Global ADCs market to grow at a CAGR of 41.58% during the period 2016-2020

About Antibody Drug Conjugates

ADCs, empowered monoclonal antibodies (mAbs), use chemical linkers with labile bonds to attach biologically active substances. ADCs target mAbs with the cancer killing ability of cytotoxic drugs, allowing sensitive discernment between healthy and diseased tissue.
Antibodies are the proteins produced by B-cells (from bone marrow) in the immune system. These proteins attach to antigens, which act as markers, and are then destroyed by phagocytes. B-cells produce different antibodies that attach to different sites of an antigen. mAbs, complex proteins with high molecular weight, are monospecific as they are the clones of a single parent cell. They are of three types, chimeric, humanized, and fully human, and are often used for therapeutic and diagnostic purposes.


Technavios analysts forecast the global ADCs market to grow at a CAGR of 41.58% during the period 2016-2020.

Covered in this report 
The report covers the present scenario and the growth prospects of the global ADCs market for the period 2015-2020. To calculate the market size, the report considers revenue generated from the sales of ADCs used to treat cancer.

The market is divided into the following segments based on geography: 
Americas
APAC
EMEA

Technavio's report, Global Antibody Drug Conjugates Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors 
F. Hoffmann-La Roche AG
Seattle Genetics Inc.
Takeda Pharmaceutical Company

Other prominent vendors 
AbbVie
AbGenomics
ADC Therapeutics
Agensys
ALMAC Group
Ambrx
Astellas Pharma
AstraZeneca
Bayer HealthCare
CARBOGEN AMCIS
Celldex Therapeutics
Daiichi Sankyo
Endo Pharmaceuticals
Esperance Pharmaceuticals

Read All Medical Equipments Market Research Reports @ http://www.researchmoz.us/medical-equipments-market-reports-109.html

Formation Biologics
Genmab
GlaxoSmithKline
Immunogen
Kairos Therapeutics
MedImmune
Mersana Therapeutics
Novartis
Oxford Biotherapeutics
Pfizer
Stemcentrx
Synthon Biopharmaceuticals
Zymeworks

Market driver 
Robust late-stage pipeline
For a full, detailed list, view our report

Market challenge 
High developmental costs
For a full, detailed list, view our report

Market trend 
Strategic alliances
For a full, detailed list, view our report


Key questions answered in this report 
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.

For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare, +1–518–621–2074
USA-Canada Toll Free: 866–997–4948
Follow us on LinkedIn at: http://bit.ly/1TBmnVG

Thursday 23 June 2016

New report sheds light on Global Dental Consumables Market Research 2016, Trends and Forecast Report

2016 Global Dental Consumables Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Dental Consumables industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China).

The report firstly introduced the Dental Consumables basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.


The report includes six parts, dealing with: 1.) basic information; 2.) the Asia Dental Consumables industry; 3.) the North American Dental Consumables industry; 4.) the European Dental Consumables industry; 5.) market entry and investment feasibility; and 6.) the report conclusion.

Chapter Two Dental Consumables Up and Down Stream Industry Analysis

2.1 Upstream Raw Materials Analysis
2.1.1 Upstream Raw Materials Price Analysis
2.1.2 Upstream Raw Materials Market Analysis
2.1.3 Upstream Raw Materials Market Trend
2.2 Down Stream Market Analysis
2.1.1 Down Stream Market Analysis
2.2.2 Down Stream Demand Analysis
2.2.3 Down Stream Market Trend Analysis

Part II Asia Dental Consumables Industry (The Report Company Including the Below Listed But Not All)

Chapter Three Asia Dental Consumables Market Analysis

3.1 Asia Dental Consumables Product Development History
3.2 Asia Dental Consumables Process Development History
3.3 Asia Dental Consumables Industry Policy and Plan Analysis
3.4 Asia Dental Consumables Competitive Landscape Analysis
3.5 Asia Dental Consumables Market Development Trend

Get Report Sample and Customization: http://www.researchmoz.us/enquiry.php?type=S&repid=726690

Chapter Four 2011-2016 Asia Dental Consumables Productions Supply Sales Demand Market Status and Forecast

4.1 2011-2016 Dental Consumables Capacity Production Overview
4.2 2011-2016 Dental Consumables Production Market Share Analysis
4.3 2011-2016 Dental Consumables Demand Overview
4.4 2011-2016 Dental Consumables Supply Demand and Shortage
4.5 2011-2016 Dental Consumables Import Export Consumption
4.6 2011-2016 Dental Consumables Cost Price Production Value Gross Margin

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare, +1–518–621–2074
USA-Canada Toll Free: 866–997–4948
Follow us on LinkedIn at: http://bit.ly/1TBmnVG